CD8A and neoplasm: This indicates that while a TCM phenotype (CD62Lhigh) is generally considered desirable for an anti-tumor response [32], the presence of a larger number of CD8+ T cells with an effector function (TEM, CD62Llow) may compensate, leading to equivalent tumor protection, at least in this tumor model.